Yuksel Serdar, Guleç M Akif, Gultekin M Zeki, Adanır Oktay, Caglar Aysel, Beytemur Ozan, Onur Küçükyıldırım B, Avcı Ali, Subaşı Cansu, İnci Çiğdem, Karaoz Erdal
a Trabzon Kanuni Training and Research Hospital , Department of Orthopaedic and Traumatology , Trabzon , Turkey.
b Bağcılar Training and Research Hospital , Department of Orthopaedic and Traumatology , Istanbul , Turkey.
Connect Tissue Res. 2016 Sep;57(5):360-73. doi: 10.1080/03008207.2016.1189909. Epub 2016 May 18.
This study aims to histopathologically, biomechanically, and immunohistochemically compare the fourth-week efficiencies of local platelet-rich plasma (PRP) and bone marrow-derived mesenchymal stem cell (rBM-MSC) treatments of the Achilles tendon ruptures created surgically in rats.
The study included 35 12-month-old male Sprague Dawley rats, with an average weight of 400-500 g. Five rats were used as donors for MSC and PRP, and 30 rats were separated into MSC, PRP, and control groups (n = 10). The Achilles tendons of the rats were cut transversely, the MSC from bone marrow was administered to the MSC group, the PRP group received PRP, and the control group received physiological saline to create the same surgical effect. In previous studies, it was shown that this physiological saline does not have any effect on tendon recovery. Thirty days after the treatment, the rats were sacrificed and their Achilles tendons were examined histopathologically, immunohistochemically, and biomechanically.
The use of rBM-MSC and PRP in the Achilles tendon ruptures when the tendon is in its weakest phase positively affected the recovery of the tendon in histopathologic, immunohistochemical, and biomechanical manners compared to the control group (p < 0.05). While the levels of pro-inflammatory cytokines TNF-α, IFNγ, and IL 1β were significantly low, the levels of anti-inflammatory cytokines and growth factors playing key roles in tendon recovery, such as IL2, VEGF, transforming growth factor-beta, and HGF, were significantly higher in the MSC group than those of the PRP and control groups (p < 0.05). In the MSC group, the [Formula: see text] (mm) value was significantly higher (p ˂ 0.05) than that in the PRP and control groups.
rBM-MSC and PRP promote the recovery of the tendon and increase its structural strength. The use of PRP and MSC provides hope for the treatment of the Achilles tendon ruptures that limit human beings' functionalities and quality of life, particularly for athletes. It is thought that the use of MSC can be more effective for tendon healing; hence, more extensive and advanced studies are needed on this topic.
本研究旨在从组织病理学、生物力学和免疫组织化学方面,比较局部富血小板血浆(PRP)和骨髓源性间充质干细胞(rBM-MSC)对大鼠手术造成的跟腱断裂进行治疗四周后的效果。
本研究纳入35只12月龄雄性斯普拉格-道利大鼠,平均体重400 - 500克。5只大鼠用作MSC和PRP的供体,30只大鼠分为MSC组、PRP组和对照组(n = 10)。将大鼠的跟腱横向切断,向MSC组给予骨髓来源的MSC,PRP组接受PRP,对照组接受生理盐水以产生相同的手术效果。在先前的研究中表明,这种生理盐水对肌腱恢复没有任何影响。治疗30天后,处死大鼠并对其跟腱进行组织病理学、免疫组织化学和生物力学检查。
与对照组相比,在跟腱处于最薄弱阶段时使用rBM-MSC和PRP进行跟腱断裂治疗,在组织病理学、免疫组织化学和生物力学方面对肌腱恢复产生了积极影响(p < 0.05)。虽然促炎细胞因子TNF-α、IFNγ和IL 1β的水平显著较低,但在肌腱恢复中起关键作用的抗炎细胞因子和生长因子,如IL2、VEGF、转化生长因子-β和HGF,在MSC组中的水平显著高于PRP组和对照组(p < 0.05)。在MSC组中,[公式:见正文](mm)值显著高于PRP组和对照组(p ˂ 0.05)。
rBM-MSC和PRP可促进肌腱恢复并增加其结构强度。PRP和MSC的使用为治疗限制人类功能和生活质量的跟腱断裂,特别是对运动员而言,带来了希望。据认为,MSC的使用对肌腱愈合可能更有效;因此,需要对该主题进行更广泛和深入的研究。